These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7879198)

  • 1. Assessment of glomerular filtration rate after multiple administration of a new oral formulation of cyclosporine in clinically stable renal transplant patients.
    Mueller EA; Kallay Z; Kovarik JM; Arns W; Renner E; Kutz K
    Transplant Proc; 1995 Feb; 27(1):834-6. PubMed ID: 7879198
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral cimetidine improves the accuracy of creatinine clearance in transplant patients on cyclosporine.
    Marcen R; Serrano P; Teruel JL; Rivera ME; Mitjavila M; Navarro J; Orofino L; Sabater J; Ortuño J
    Transplant Proc; 1994 Oct; 26(5):2624-5. PubMed ID: 7940817
    [No Abstract]   [Full Text] [Related]  

  • 3. Excessive cyclosporine trough level variation with classic cyclosporine can be reduced with the new oral microemulsion formulation of cyclosporine.
    Bökenkamp A; Offner G; Hoyer PF; Wonigeit K; Brodehl J
    Transplant Proc; 1996 Aug; 28(4):2273-5. PubMed ID: 8769223
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term results of conversion from existing to microemulsion formulation of cyclosporine.
    Neumayer HH; Färber L; Budde K; Kohnen R; Maibücher A; Schuster A; Vollmar J; Waiser J; Luft FC
    Transplant Proc; 1996 Aug; 28(4):2207-13. PubMed ID: 8769202
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of nifedipine on renal haemodynamics and urinary protein excretion in stable renal transplant recipients.
    Wilkie ME; Beer JC; Raftery MJ; Dawnay A; Barton C; Marsh FP
    Transplant Proc; 1993 Feb; 25(1 Pt 1):612-5. PubMed ID: 8438435
    [No Abstract]   [Full Text] [Related]  

  • 6. The Neoral formulation: improved correlation between cyclosporine trough levels and exposure in stable renal transplant recipients.
    Kahan BD; Dunn J; Fitts C; Van Buren D; Wombolt D; Pollak R; Carson R; Alexander JW; Chang C; Choc M
    Transplant Proc; 1994 Oct; 26(5):2940-3. PubMed ID: 7940928
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical experience in transferring kidney transplant patients from sandimmun to sandimmun neoral--results after 6 months.
    Neumayer HH; Färber L; Haller P; Kohnen R; Maibücher A; Schuster A; Vollmar J; Waiser J
    Transplant Proc; 1995 Oct; 27(5):2679-82. PubMed ID: 7482873
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of the new cyclosporine formulation, Consupren, in renal transplant patients.
    Stephan AG; Barbari A; Masri MA; Rizk S; Moubarak R; Frem GJ; Kamel G; Baracat-Khoury W; Karam A
    Transplant Proc; 1996 Jun; 28(3):1348-9. PubMed ID: 8658688
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of different methods of estimating glomerular filtration rate in cyclosporine-treated renal transplant patients.
    Germain MJ; Lipkowitz GS; Guarnera J; Fiorentino J
    Transplantation; 1993 Jan; 55(1):203-5. PubMed ID: 8420049
    [No Abstract]   [Full Text] [Related]  

  • 10. Conversion from Sandimmun to Sandimmun Neoral in patients with stable renal allografts: results after 1 month.
    Neumayer HH; Färber L; Haller P; Kohnen R; Maibücher A; Schuster A; Vollmar J; Waiser J
    Transplant Proc; 1994 Oct; 26(5):2944-8. PubMed ID: 7940929
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclosporine-A-based immunosuppression and renal functional reserve in organ-transplant patients.
    Kamar N; Allard J; Ader JL; Rostaing L
    Transplant Proc; 2004 Mar; 36(2 Suppl):248S-250S. PubMed ID: 15041347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The beneficial effects of isradipine on renal hemodynamics in cyclosporine-treated renal transplant recipients.
    McCrea JB; Francos GF; Burke JF; Michael HJ; Besarab A
    Transplantation; 1993 Mar; 55(3):672-4. PubMed ID: 8456491
    [No Abstract]   [Full Text] [Related]  

  • 13. Sandimmun neoral, a new oral formulation of cyclosporin A with improved pharmacokinetic characteristics: safety and tolerability in renal transplant patients.
    Taesch S; Niese D; Mueller EA
    Transplant Proc; 1994 Dec; 26(6):3147-9. PubMed ID: 7998097
    [No Abstract]   [Full Text] [Related]  

  • 14. Six-month clinical outcome of cyclosporine microemulsion formulation (Sigmasporin Microral) in stable renal transplant patients previously maintained on sandimmun neoral.
    Al Wakeel JS; Shaheen FA; Mathew MC; Abou Zeinab HM; Al Alfi A; Tarif NM; Al Mousawi MS; Mahmoud TS; Alorrayed AS; Fagir EA; Dham RS; Shaker DS
    Transplant Proc; 2008 Sep; 40(7):2245-51. PubMed ID: 18790205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between glomerular filtration rate and renal plasma flow between kidney and heart transplant recipients maintained on a similar cyclosporine dosage.
    Lloveras JJ; Durand D; Ader JL; Tran Van T; Tack I; Rostaing L; Suc JM
    Transplant Proc; 1994 Feb; 26(1):248. PubMed ID: 8108961
    [No Abstract]   [Full Text] [Related]  

  • 16. Enalapril and cyclosporin in renal transplant patients and rats.
    Ferguson CJ; von Ruhland C; Shrestha B; Griffin PJ; Moore RH; Salaman JR
    Transplant Proc; 1994 Oct; 26(5):2600-1. PubMed ID: 7940808
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term renal function in heart transplant recipients receiving cyclosporine therapy.
    Goral S; Ynares C; Shyr Y; Yeoh TK; Johnson HK
    J Heart Lung Transplant; 1997 Nov; 16(11):1106-12. PubMed ID: 9402509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the pharmacokinetics of cyclosporine Sandimmune with Sandimmune Neoral in stable renal transplant patients.
    Sketris IS; Lawen JG; Beauregard-Zollinger L; Belitsky P; Landsberg D; Givner ML; Keown P
    Transplant Proc; 1994 Oct; 26(5):2961-3. PubMed ID: 7940935
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of conversion from Sandimmune to Neoral on glomerular filtration rate in stable renal transplant recipients.
    Steinmuller D; Dougherty J; Coutee J; Surek D; Swies G; Lewis R
    Transplant Proc; 1997; 29(1-2):298-9. PubMed ID: 9123005
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal effects of L-arginine infusion in cyclosporine-treated transplant recipients.
    Viganò E; Badalamenti S; Paone G; Como G; Finazzi S; Tarantino A; Galmarini D; Ponticelli C
    Transplant Proc; 1994 Oct; 26(5):2622-3. PubMed ID: 7940816
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.